Mitochondrial Research Compounds: MOTS-c, SS-31, NAD+ & Pinealon

Mitochondrial and cellular-stress research covers chemically different materials, not one class of "longevity peptides." MOTS-c and SS-31 (elamipretide) are peptides studied in mitochondrial biology, while NAD+ is a nucleotide coenzyme rather than a peptide. Pinealon is a short peptide investigated mainly in cellular models of neuronal and oxidative stress, without an established mitochondrial target. This article compares the four without implying that they share a mechanism, slow ageing, or benefit humans; most of the evidence discussed is preclinical.

The common thread: cellular energy and the mitochondrion

Mitochondria generate most cellular ATP through oxidative phosphorylation and also participate in redox signalling, metabolite production, calcium handling, and regulated cell death. MOTS-c, SS-31, and NAD+ each connect directly to some part of mitochondrial function or bioenergetics. That overlap is why they appear together in our mitochondrial and cellular research catalogue. Pinealon is included here as a comparison with a different cellular-stress research tradition, not because a mitochondrial target has been established for it.

Their experimental roles differ. MOTS-c is a mitochondrially encoded signalling peptide. SS-31 is studied for its interaction with cardiolipin in the inner mitochondrial membrane. NAD+ carries electrons in metabolic redox reactions and is also consumed as a substrate by enzymes including sirtuins, PARPs, and CD38. Pinealon comes from Russian short-peptide research and has been examined in cell models measuring reactive oxygen species, viability, signalling, and cell-cycle effects.

A quick comparison

MOTS-c: a signal from inside the mitochondrion

MOTS-c is unusual. Most peptides are transcribed from the cell's nuclear genome; MOTS-c is read out of an open reading frame hidden inside the mitochondrial 12S rRNA gene, which makes it a mitochondrial-derived peptide. Under metabolic stress it moves out of the mitochondrion, and the published mechanism runs through the folate–methionine one-carbon cycle to switch on AMPK — the same energy-sensing kinase engaged by exercise and by metformin. A second arm sees it translocate to the nucleus and work with NRF2 on stress-defence genes.

That makes MOTS-c a reference tool for studying retrograde signalling — how a stressed mitochondrion talks back to the nucleus. The foundational work, from Changhan David Lee and Pinchas Cohen at USC, reported that MOTS-c activated AMPK and countered diet- and age-related insulin resistance in mice (Lee, Cell Metabolism, 2015). The evidence base is essentially all cell-culture and mouse work, with no established human protocols.

SS-31 (elamipretide): protecting the inner membrane

SS-31 is studied through its interaction with mitochondrial membranes rather than as a mitochondrially encoded signal. It is a small aromatic-cationic tetrapeptide from the Szeto-Schiller series that accumulates at the inner mitochondrial membrane and binds cardiolipin, a phospholipid involved in cristae organisation and electron-transport-chain function.

Cardiolipin oxidation and changes in cardiolipin–cytochrome c interactions are among the alterations observed during mitochondrial stress; they can affect cristae structure and electron transport. Published work describes SS-31 binding cardiolipin, inhibiting cytochrome c peroxidase activity, and preserving cristae in experimental ischaemia (Birk, J Am Soc Nephrol, 2013). In the clinical literature the same molecule is indexed as elamipretide (the branded medicine and trial name are a separate regulatory matter from this research material), and it has been studied in both animal models and human trials.

NAD+: a redox coenzyme, not a peptide

NAD+ is the odd one out — a coenzyme, not a peptide. It cycles between oxidised and reduced forms to shuttle electrons through glycolysis, the TCA cycle, and oxidative phosphorylation, and in that role it is regenerated rather than used up. The research interest comes from its second job: sirtuins, PARP enzymes, and the ectoenzyme CD38 all consume NAD+ outright, forcing the cell to keep rebuilding it through the salvage pathway.

The central hypothesis in the ageing literature is that this balance tips with age — consumption outpaces salvage, tissue NAD+ falls, and sirtuin-dependent processes lose their substrate (Gomes, Cell, 2013). It is worth stating plainly that this is a contested field, and that most human data concern NAD+ precursors (nicotinamide riboside and NMN) rather than direct NAD+ administration. That caveat is why NAD+ belongs in a research catalogue, not a wellness one.

Pinealon: a short peptide studied in cellular-stress models

Pinealon comes from the Khavinson short-peptide research programme. It is the tripeptide Glu-Asp-Arg (EDR). In one primary cell study, Pinealon was associated with reduced reactive oxygen species accumulation and necrotic cell death, altered ERK1/2 activation timing, and cell-cycle changes in cerebellar granule cells, neutrophils, and PC12 cells under induced oxidative stress (Khavinson et al., Rejuvenation Research, 2011). These are in-vitro observations, not evidence of an anti-ageing effect.

A separate experiment detected fluorescently labelled Pinealon in the cytoplasm, nucleus, and nucleolus of HeLa cells and measured interactions with nucleic-acid preparations in vitro (Fedoreyeva et al., Biochemistry (Moscow), 2011). That result supports cellular and nuclear localisation under those experimental conditions; it does not by itself establish gene regulation, a specific genomic target, or activity in an intact organism. The evidence base is small and concentrated among overlapping research groups, so Pinealon should be treated as an early-stage research compound.

How the evidence differs

Grouping these compounds together should not flatten the differences in how well each is supported. SS-31 has the broadest evidence, spanning preclinical models and human trials. MOTS-c has a substantial, largely independent preclinical base but no established human protocols. NAD+ biology is strong preclinically, with human work concentrated on precursors. Pinealon has the smallest literature, concentrated among overlapping groups. A researcher planning a study should weight these very differently, not treat "longevity peptide" as a single tier of evidence.

Handling and storage in Thailand

These materials do not share one validated solvent or storage rule. Use material-specific evidence or an institutional protocol; the laboratory reconstitution guide and Thailand storage guide cover compatibility, receipt logging, condensation, and excursion decisions.